Scott Gottlieb tempts the FDA's fiercest critics with his leap onto Pfizer's board of directors

The next chapter of Scott Gottlieb’s career will be played out in the inner sanctums of Big Pharma — forever reinforcing the FDA’s critics of the revolving door between the agency and the industry.